Slow Art Plus: A Single Session Art Gallery-based Intervention for Mental Health Promotion (SAP)

April 6, 2023 updated by: Andy Hau Yan Ho, PhD, EdD, Nanyang Technological University

Slow Art Plus: Developing and Piloting a Single Session Art Gallery-based Intervention for Mental Health Promotion Via a Mixed Method Waitlist Randomized Control Trial (RCT)

Utilizing a Participatory Action Research (PAR) paradigm, this 12-month study will adopt a mixed method Waitlist Randomized Control Trial (RCT) with a built-in acceptability and feasibility study to test the efficacy of Slow Art Plus in reducing stress and empowering self-care among 200 participants.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The specific objectives are in four-folds: 1) To develop a standardized 90-minute single-session Slow Art Plus programme that integrates: (a) slow looking; (b) mindfulness meditation; (c) self-compassion activities; (d) reflective-creative expressions; and (e) dyadic sharing, to form a holistic mental health promotion intervention; 2) To assess the effectiveness of Slow Art Plus for reducing participants' perceived stress (primary outcomes); 3) To assess the effectiveness of Slow Art Plus for enhancing participants' self-awareness, self-care capacity, psychological resilience, and quality of life (secondary outcomes); and 4) To assess the feasibility and acceptability of the standardized Slow Art Plus protocol for large scale implementation in Singapore and greater Asia.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
200

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Singapore
      • Singapore, Singapore, 637332
        • Nanyang Technological University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

- individuals who can communicate in English and provide informed consent.

Exclusion Criteria:

  • individuals who are suffering from depression or other major mental illness.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention
The first 10-minute of Slow Art Plus involves a brief psychoeducation on slow looking, mindfulness, and self-compassion practices. This is followed by a 10-minute participants self-introduction and sharing of one act of self-kindness; a 10-minute facilitator led mindfulness meditation on affectionate breathing to foster greater somatic and emotional clarity for slow-looking. This is followed by a set of 30-minute slow looking activity with 1 selected art-piece, including: (a) creating an Artwork Title with one sentence description, (b) imaging music that resonates with the viewers' emotional response to artwork, and (c) sketching a Response Art that facilitates a dialogue between the viewer and the art piece for perspective widening. A 10-minute dyadic sharing follows with a 5-minute large group sharing of joint collective experience. Artwork reveal and sharing of its self-care implications is offered. Finally, a closure self-compassion activity of Supportive Healing Touch.
Behavioral: Slow Art Plus
Slow Art Plus involved a full 90-minute engagement, one that is built upon the existing Slow Art programme with added layers of mindfulness and self-compassion practices, as well as a response art activity that fosters symbolic dialogue and an emotional aesthetic experience between participants and the selected artwork.
No Intervention: Control
Wait-list Control Arm who will receive the Slow Art Plus after the Experimental Arm completes the Intervention.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Perceived Stress Scale (PSS)
Time Frame: Pre-Intervention
The PSS comprises 10-items rated on a 5-point Likert scale and clustered into 2 subscales of perceived helplessness (e.g., "In the past couple of days, how often have you felt nervous and stressed today"), and perceived self-efficacy (e.g., In the past couple of days, how often have you felt that things were going your way"). The PSS possesses strong internal validity, reliability, and cross-cultural applicability.
Pre-Intervention
Perceived Stress Scale (PSS)
Time Frame: Immediate Post Intervention
The PSS comprises 10-items rated on a 5-point Likert scale and clustered into 2 subscales of perceived helplessness (e.g., "In the past couple of days, how often have you felt nervous and stressed today"), and perceived self-efficacy (e.g., In the past couple of days, how often have you felt that things were going your way"). The PSS possesses strong internal validity, reliability, and cross-cultural applicability.
Immediate Post Intervention
Perceived Stress Scale (PSS)
Time Frame: 1-Day Follow-UP
The PSS comprises 10-items rated on a 5-point Likert scale and clustered into 2 subscales of perceived helplessness (e.g., "In the past couple of days, how often have you felt nervous and stressed today"), and perceived self-efficacy (e.g., In the past couple of days, how often have you felt that things were going your way"). The PSS possesses strong internal validity, reliability, and cross-cultural applicability.
1-Day Follow-UP

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Five Facet Mindfulness Questionnaire Short Form (SF-FFMQ)
Time Frame: Pre-Intervention
The SF-FFMQ comprises 20 items clustered into 5 subscales: (i) observe, (ii) describe, (iii) act with awareness, (iv) non-judging of inner experience, and (v) non-reactivity to inner experience. Higher scores indicating higher mindfulness capacity.
Pre-Intervention
Five Facet Mindfulness Questionnaire Short Form (SF-FFMQ)
Time Frame: Immediate Post Intervention
The SF-FFMQ comprises 20 items clustered into 5 subscales: (i) observe, (ii) describe, (iii) act with awareness, (iv) non-judging of inner experience, and (v) non-reactivity to inner experience. Higher scores indicating higher mindfulness capacity.
Immediate Post Intervention
Five Facet Mindfulness Questionnaire Short Form (SF-FFMQ)
Time Frame: 1-Day Follow-Up
The SF-FFMQ comprises 20 items clustered into 5 subscales: (i) observe, (ii) describe, (iii) act with awareness, (iv) non-judging of inner experience, and (v) non-reactivity to inner experience. Higher scores indicating higher mindfulness capacity.
1-Day Follow-Up
Self-Compassion Scale - Short Form (SCS-SF)
Time Frame: Pre-Intervention
The SCS-SF comprises 12 items clustered into 6 subscales: (i) self-kindness, (ii) common humanity, (iii) mindfulness, (iv) self-judgement, (v) isolation, and (iv) over-identification. Higher scores indicating higher self-compassion capacity.
Pre-Intervention
Self-Compassion Scale - Short Form (SCS-SF)
Time Frame: Immediate Post Intervention
The SCS-SF comprises 12 items clustered into 6 subscales: (i) self-kindness, (ii) common humanity, (iii) mindfulness, (iv) self-judgement, (v) isolation, and (iv) over-identification. Higher scores indicating higher self-compassion capacity.
Immediate Post Intervention
Self-Compassion Scale - Short Form (SCS-SF)
Time Frame: 1-Day Follow-Up
The SCS-SF comprises 12 items clustered into 6 subscales: (i) self-kindness, (ii) common humanity, (iii) mindfulness, (iv) self-judgement, (v) isolation, and (iv) over-identification. Higher scores indicating higher self-compassion capacity.
1-Day Follow-Up
Ego-Resilience Scale-11 (ER-11)
Time Frame: Pre-Intervention
The ER-11 comprises 11-items clustered into 3 subscales: (i) active engagement with the world, (ii) repertoire of problem-solving strategies, and (iii) integrated performance under stress. Higher scores indicating higher ego-resilience.
Pre-Intervention
Ego-Resilience Scale-11 (ER-11)
Time Frame: Immediate Post Intervention
The ER-11 comprises 11-items clustered into 3 subscales: (i) active engagement with the world, (ii) repertoire of problem-solving strategies, and (iii) integrated performance under stress. Higher scores indicating higher ego-resilience.
Immediate Post Intervention
Ego-Resilience Scale-11 (ER-11)
Time Frame: 1-Day Follow-Up
The ER-11 comprises 11-items clustered into 3 subscales: (i) active engagement with the world, (ii) repertoire of problem-solving strategies, and (iii) integrated performance under stress. Higher scores indicating higher ego-resilience.
1-Day Follow-Up
Single-Item Quality of Life Scale (SI-QOLS)
Time Frame: Pre-Intervention
1 item measures quality of life. Higher scores indicating higher QOL.
Pre-Intervention
Single-Item Quality of Life Scale (SI-QOLS)
Time Frame: Immediate Post Intervention
1 item measures quality of life. Higher scores indicating higher QOL.
Immediate Post Intervention
Single-Item Quality of Life Scale (SI-QOLS)
Time Frame: 1-Day Follow-Up
1 item measures quality of life.
1-Day Follow-Up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Nanyang Technological University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
National Gallery Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
July 14, 2022

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2023

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 31, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 22, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 6, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 7, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 7, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 6, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 04IDP001152C430

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings